benzothiazide has been researched along with Atrophy in 1 studies
benzothiazide: structure
benzthiazide : 7-Sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by chlorine and that at position 3 is substituted by a benzylsulfanylmethyl group. A diuretic, it is used to treat hypertension and edema.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takeuchi, A | 1 |
| Takahashi, Y | 1 |
| Iida, K | 1 |
| Hosokawa, M | 1 |
| Irie, K | 1 |
| Ito, M | 1 |
| Brown, JB | 1 |
| Ohno, K | 1 |
| Nakashima, K | 1 |
| Hagiwara, M | 1 |
1 other study available for benzothiazide and Atrophy
| Article | Year |
|---|---|
Identification of Qk as a Glial Precursor Cell Marker that Governs the Fate Specification of Neural Stem Cells to a Glial Cell Lineage.
Topics: Animals; Astrocytes; Atrophy; Biomarkers; Brain; Cell Differentiation; Cell Lineage; Endocytosis; Mi | 2020 |